Syndax Pharmaceuticals SNDX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.06B.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's market capitalization?
- Syndax Pharmaceuticals (SNDX) reported market capitalization of $2.06B in Q1 2026.
- How has Syndax Pharmaceuticals's market capitalization changed year-over-year?
- Syndax Pharmaceuticals's market capitalization increased by 95.0% year-over-year, from $1.06B to $2.06B.
- What is the long-term trend for Syndax Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's market capitalization has grown at a 8.8% compound annual growth rate (CAGR), from $1.2B to $1.83B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.